The Emerging Role of CFTR Combination Regimens in Improving Outcomes for Patients With Cystic Fibrosis

http://academiccme.com/wp-content/uploads/2017/12/910742E-116-x-140-wpcf_400x400.jpg

Course Information

Therapautic Area: Pulmonolgy
Format(s): Webcast
Credit(s): 1.50 AMA PRA Category 1 Credit(s)™ and 1.50 contact hours
Activity Dates: December 18, 2017 to December 17, 2018

 

Program Overview

The content for this activity is based on the live, inter professional seminar titled, “The Emerging Role of CFTR Combination Regimens in Improving Outcomes for Patients With Cystic Fibrosis” that was presented at the 31stth Annual North American Cystic Fibrosis Conference in Indianapolis, Indiana. This CME/CNE activity will highlight the latest advances in CFTR-based therapeutics for the treatment of patients with cystic fibrosis. The expert faculty will utilize an interactive panel format to present and discuss recent trial data as it relates to clinical decision-making, including updates regarding the assessment, monitoring, and management of patients treated with CFTR modulated therapies. This educational activity is intended to increase the knowledge and competencies of the multidisciplinary team involved in the care of the CF patient population. Upon completion of this educational activity, the healthcare team will be better equipped with vital information for improving outcomes and quality of life in patients with cystic fibrosis.

Target Audience

This activity has been designed to meet the educational needs of health care professionals involved in the diagnosis, treatment, or management of patients with cystic fibrosis.

Learning Outcomes Statement

At the conclusion of this activity:

KNOWLEDGE: Participants will self-report knowledge gained based on current best practices for improving outcomes and quality of life in patients with cystic fibrosis.

COMPETENCE/SKILL: Participants will self-report intent to change practice by applying current best practices for improving outcomes and quality of life in patients with cystic fibrosis.

Educational Objectives

  1. Review pathophysiology, genomic evaluation and functional implications of CF, including the underlying causing of disease to guide therapeutic selection
  2. Examine clinical trial data of emerging combination therapies for the treatment of CF
  3. Implement a data-driven and personalized CFTR modulated treatment plan to improve the life-long management of patients with CF

Faculty

Clancy HeadshotJohn P. Clancy, MD
Professor of Pediatrics
Director, Pulmonary Medicine Research
Co- Director, CF Research Development Program
Medical Director, Office of Clinical and Translational Research Gunnar Esiason/Cincinnati Bell Chair in Life Sciences Research Division of Pulmonary Medicine
Cincinnati Children’s Hospital Medical Center
Cincinnati, Ohio

 

Screen Shot 2017-12-20 at 3.17.57 PMJane Davies, MD
Professor of Paediatric Respirology and Experimental Medicine
Imperial College London
Honorary Consultant in Paediatric Respiratory Medicine
Royal Brompton and Harefield NHS Foundation Trust
London, United Kingdom

 

 

 

Screen Shot 2017-12-20 at 3.20.40 PMCarlos Milla, MD
Professor and Director
The Stanford Cystic Fibrosis Center
Associate Director for Translational Research
Center for Excellence in Pulmonary Biology
Stanford University
Palo Alto, California

 

 

Riekert HeadshotKristin A. Riekert, PhD
Associate Professor
Director, Johns Hopkins Adherence Research Center
Director, Cystic Fibrosis Adherence Program
Johns Hopkins School of Medicine
Baltimore, Maryland

 

 

 

Sawicki Head ShotGregory Sawicki, MD, MPH
Director, Cystic Fibrosis Center
Boston Children’s Hospital
Assistant Professor of Pediatrics
Harvard Medical School
Boston, Massachusetts

 

 

JTaylor-Cousar Head Shot copyennifer L. Taylor-Cousar, MD, MSCS
Medical Director, Clinical Research Services
Co-Director and CF TDN Director, Adult CF Program
Associate Professor, Departments of Medicine and Pediatrics,
Divisions of Pulmonary, Critical Care and Sleep Medicine and Pediatric Pulmonary Medicine
Denver, Colorado

 



 

Registration

Provided in collaboration with the Elsevier Office of Continuing Medical Education, Elsevier and AcademicCME. eocme-acme-logo